Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-12-03T15:05:36.486Z Has data issue: false hasContentIssue false

Chapter 34 - Use of Botulinum Toxin in the Treatment of Low Back Pain

Published online by Cambridge University Press:  02 November 2023

Daniel Truong
Affiliation:
University of California, Riverside
Dirk Dressler
Affiliation:
Hannover Medical School
Mark Hallett
Affiliation:
National Institutes of Health (NIH)
Christopher Zachary
Affiliation:
University of California, Irvine
Mayank Pathak
Affiliation:
Truong Neuroscience Institute
Get access

Summary

Chronic low back pain (CLPB) is one of the leading causes of physician office visits and work absenteeism in developed countries. Because many of the muscle groups involved in CLBP are easily accessible and respond well to injection, this disorder may be seen as particularly amenable to treatment with botulinum neurotoxin (BoNT). This chapter reviews the pathophysiology, diagnosis and treatment with BoNT of myofascial pain of muscles involved in lumbosciatic conditions (quadratus lumborum, iliopsoas and paravertebral). Physical examination of the patient is discussed and illustrated. Anatomy is reviewed, and anatomical diagrams are provided, along with discussion of guidance techniques, such as fluoroscopy, for the accurate placement and dosing of injections.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agten, CA, Rosskopf, AB, Zingg, PO et al. (2015). Outcomes after fluoroscopy-guided iliopsoas bursa injection for suspected iliopsoas tendinopathy. Eur Radiol, 25, 865–71.CrossRefGoogle ScholarPubMed
Curatolo, M, Eichenberger, U (2007). Ultrasound-guided blocks for the treatment of chronic pain. Tech Reg Anesth Pain Med, 11, 95102.CrossRefGoogle Scholar
Cogné, M, Petit, H, Creuzé, A et al. (2017). Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial. BMC Musculoskelet Disord, 18, 454.CrossRefGoogle ScholarPubMed
De Andres, J, Cerda-Olmedo, G, Valia, JC et al. (2003). Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain, 19, 269–75.Google Scholar
De Andres, J, Martorell-Adsuara, V, Palmisani, S et al. (2010). A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. Reg Anesth Pain Med, 35, 255–60.CrossRefGoogle ScholarPubMed
Donnelly, JM, Fernández-de-Las-Peñas, C, Finnegan, M, Freeman, JL (2018). Travell, Simons & Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual, 3rd ed. Philadelphia: Wolters Kluwer.Google Scholar
Fish, DE, Chang, WS (2007). Treatment of iliopsoas tendinitis after a left total hip arthroplasty with botulinum toxin type A. Pain Physician, 10, 565–71.Google ScholarPubMed
Foster, L, Clapp, L, Erickson, M et al. (2001). Botulinum toxin A and chronic low back pain. Neurology, 56, 1290–3.CrossRefGoogle ScholarPubMed
Goubert, D, Oosterwijck, JV, Meeus, M, Danneels, L (2016). Structural changes of lumbar muscles in non-specific low back pain: a systematic review. Pain Physician, 19, E985E1000.Google ScholarPubMed
Han, JS, Sugimoto, D, McKee-Proctor, MH et al. (2019). Short-term effect of ultrasound-guided iliopsoas peritendinous corticosteroid injection. J Ultrasound Med 38, 1527–36.CrossRefGoogle ScholarPubMed
Jabbari, B, Ney, J. Sichani, A et al. (2006). Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label pilot study. Pain Med, 7, 60–4.CrossRefGoogle ScholarPubMed
Lawry, G, Kreder, H, Hawker, G et al. (2010). Fam’s Musculoskeletal Examination and Joint Injection Techniques, 2nd ed. Philadelphia: Mosby.Google Scholar
Machado, D, Kumar, A, Jabbari, B (2016). Abobotulinum toxin a in the treatment of chronic low back pain. Toxins, 8, 374.CrossRefGoogle ScholarPubMed
Malanga, GA, Cruz Colon, EJ (2010). Myofascial low back pain: a review. Phys Med Rehabil Clin N Am, 21, 711–24.Google Scholar
Manchikanti, L, Singh, V, Falco, FJ et al. (2014). Epidemiology of low back pain in adults. Neuromodulation, 17, (Suppl 2), 310.CrossRefGoogle ScholarPubMed
Ney, JP, Difazio, M, Sichani, A et al. (2006). Treatment of chronic low back pain with successive injections of botulinum toxin A over 6 months: a prospective trial of 60 patients. Clin J Pain, 22, 363–9.Google Scholar
Raj, PP (2004). Treatment algorithm overview: BoNT therapy for pain. Pain Pract, 4, S54S67.Google Scholar
Westhoff, B, Seller, K, Wild, A et al. (2003). Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle. Dev Med Child Neurol, 45, 829–32.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×